Steatohepatitis/Metabolic Liver Disease News

Study results showed that while treatment with Ocaliva for nonalcoholic steatohepatitis led to an increase in LDL cholesterol at 12 weeks, levels reverted to baseline 24 weeks after discontinuation.

Chemotherapy combined with hepatic arterial infusion of floxuridine or with selective internal radiotherapy induced antitumor activity among patients with unresectable intrahepatic cholangiocarcinoma, according to results of separate phase 2 studies published in JAMA Oncology.

Researchers determined that higher liver fat content independent of BMI correlated with an adverse cardio-metabolic risk profile among children.

Gilead Sciences announced a strategic collaboration with Glympse Bio for clinical development of nonalcoholic steatohepatitis therapy, according to a press release.

The FDA granted fast track designation to Terns Pharmaceuticals for TERN-101, an investigational farnesoid X receptor being evaluated for nonalcoholic steatohepatitis, according to a press release.

SAN ANTONIO — In this exclusive video from the National Liver Conference 2019, Stephen A. Harrison, MD, medical director of Pinnacle Clinical Research in San Antonio, provides an overview of the topics discussed at the meeting ranging from nonalcoholic steatohepatitis to hepatitis B to liver cancer.

SAN ANTONIO – At this year’s American College of Gastroenterology Annual Meeting, Healio honored Disruptive Innovators in seven different categories.

SAN ANTONIO — The National Liver Congress will convene October 25th, providing a broad scientific program and exhibit of products and services important for all practitioners involved in the care of patients with liver disease.

CHICAGO — Researchers determined clinical scores that assessed short-term risks for liver disease associated with isolated heart transplantation with the Fontan procedure in pediatric patients, according to a study presented at NASPGHAN 2019.

CHICAGO — During this year’s North American Society for Pediatric Gastroenterology, Hepatology & Nutrition annual meeting, Mercedes Martinez, MD, from the New York-Presbyterian Columbia University Irving Medical Center in New York, will co-host the Single Topic Symposium on Chronic Liver Disease Management for the Gastroenterologist.